This site is a B2B information site for professional use - clinical diagnostics products listed are for
Research Use Only unless otherwise stated.
PALLCHEK Meets FDA Approval for Evaluation of Microbial Contamination in Pharmaceuticals
For the first time the FDA have approved the use of ATP bioluminescence for the evaluation of microbial contamination in the pharmaceutical industry.
PALLCHEK is the first Rapid Microbiology System, based on ATP bioluminescence, that has successfully and completely met the necessary requirements needed for getting the FDA approval under Process Analytical Technologies (PAT) initiative, as a test method for pharmaceutical product release.
Routine usage of the PALLCHEK Rapid Microbiology System requires only a modest financial investment. It is easy to validate, offering a rapid return of the economical investment.
Visit the Pall Website at pall.com to find out more about the GeneDisc® Rapid Microbiology System.
NOTE: This item is from our 'historic' database and may contain information which is not up to date.